Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrés J.M. Ferreri
Observed names:
Andrés J. M. Ferreri,
Andrés JM Ferreri
Institutions:
Vita-Salute San Raffaele University,
IRCCS Ospedale San Raffaele,
IRCCS San Raffaele Roma
Observed institutions:
Vita-Salute San Raffaele University,
European Society for Medical Oncology,
IRCCS Ospedale San Raffaele,
IRCCS San Raffaele Roma
ORCID:
0000-0001-9606-6124
Observed ORCID:
0000-0001-9606-6124
OpenAlex ID:
A5110185174
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
2024
·
Maurizio Martelli
, Luca Ceriani
, et al.
·
Journal of Clinical Oncology
·
44
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up
2024
·
Andrés J. M. Ferreri
, Gerald Illerhaus
, et al.
·
HemaSphere
·
34
PDF
Three‐Hour Infusion of Methotrexate at 3 g/m 2 With or Without Intrathecal Chemotherapy Significantly Reduces CNS Relapses and Improves Survival in Patients With Large B‐Cell Lymphomas at Increased CNS Risk
2026
·
Andrés J. M. Ferreri
, Federico Erbella
, et al.
·
American Journal of Hematology
·
2
Current therapeutic approaches to primary CNS lymphoma
2003
·
Andrés JM Ferreri
, Stefania Dell’Oro
, et al.
·
Expert Review of Neurotherapeutics
·
2
SOHO State of the Art Updates and Next Questions | Management of Primary Central Nervous System Lymphoma
2026
·
Paolo Fiore
, Teresa Calimeri
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
5
Citation count:
82
H-index:
2
I10-index:
2
Year
Topic
Type